We therefore set out to investigate whether the TRAIL/TRAIL-R system influences the tumor immune microenvironment through paracrine cytokine signaling and, if so, to what extent endogenous TRAIL/TRAIL-R-induced modulation of the cancer microenvironment might affect tumor growth. The gene discussed is TNFSF10; the disease is cancer.